Fibrin Sealants Market - Forecast(2024 - 2030)

Report Code: HCR 0095 Report Format: PDF + Excel

Fibrin Sealants Market Overview

Fibrin Sealants Market Size is estimated to reach $947 million by 2027. Furthermore, it is poised to grow at a CAGR of 7.5% over the forecast period of 2022-2027. Fibrin sealant also known as fibrin glue is human thrombin and fibrinogen, hemostatic, tissue sealing agents and tissue adhesive that is used in to close the wounds, minimise leakage and bleeding, enhance wound healing, and prevent adhesion. Human thrombin, refined, virus-inactivated human fibrinogen, and occasionally additional ingredients such as bovine aprotinin, chondrogenic make up the fibrin sealants. The mixing of fibrinogen, thrombin and other ingredients causes a semi-rigid elastic clot to form, simulating the final step of blood coagulation. Blood coagulation, also known as clotting, is the transformation of blood from a liquid to a gel, resulting in the formation of a blood clot. The clot that forms help with haemostasis and tissue sealing, and is totally absorbed during wound healing without causing a foreign body reaction or fibrosis. Fibrin Sealants are absorbable and biodegradable biological agent. The growing prevalence of cardiovascular diseases and blood disorders, increase in the number of surgical procedures as well as growing geriatric population are some of the factors driving the Fibrin Sealants Market growth during the forecast period 2022-2027.

Report Coverage

The report: “Fibrin Sealants Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Fibrin Sealants Market.

By Type- Liquid and Patches.
By Application: Cardiovascular Surgery, Thoracic Surgery, Orthopaedic Surgery, Neurosurgery, Dental Surgery, Others.
By End Users- Hospitals, Specialty Clinics, Ambulatory Surgical Centres, Others.
By Technology- Viral Inactivation, Autologous Donation, Recombinant Production, Others.
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

  • Geographically, North America held a dominant market share in the year 2021 on account of health-care infrastructure which is well developed, and an increase in the number of surgeries performed and prevalence of chronic diseases. Asia-Pacific is expected to offer lucrative growth opportunities to the manufacturers owing to the increasing geriatric population with high risk of being susceptible to cardiovascular diseases, demand for better healthcare facilities and increase in healthcare expenditure. The robust growth of cardiovascular surgeries segment is predicted to augment the market growth during the forecast period of 2022-2027.
  • Increasing prevalence of cardiovascular disease and blood disorders is estimated to drive the market growth of Fibrin Sealants Market. High cost of fibrin sealants as well as postponement of surgeries owing to pandemic situation poses threat to the market growth.
  • A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Fibrin Sealants Market Report.

Fibrin Sealants Market: Market Share (%) by region, 2021